Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

6.95
-0.3998-5.44%
Volume:368.85K
Turnover:2.65M
Market Cap:254.61M
PE:-0.89
High:7.53
Open:7.20
Low:6.85
Close:7.35
52wk High:16.34
52wk Low:1.85
Shares:36.63M
Float Shares:10.87M
Volume Ratio:4.46
T/O Rate:3.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7800
EPS(LYR):-4.8000
ROE:-3439.35%
ROA:-25.32%
PB:-0.82
PE(LYR):-1.45

Loading ...

Armata Pharma Amends 8-K to Disclose Director Daniel Gilmer Committee Assignment

Reuters
·
Yesterday

Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday

MT Newswires Live
·
Jun 23

Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant

Dow Jones
·
Jun 23

Armata Pharmaceuticals receives additional USD 2.5 million DoD funding for AP-SA02 program

Reuters
·
Jun 23

Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding From the U.S. Department of Defense to Support AP-Sa02

THOMSON REUTERS
·
Jun 23

Armata Pharmaceuticals shareholders elect seven directors at annual meeting

Reuters
·
Jun 17

BRIEF-Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update

Reuters
·
May 14

Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY

Benzinga
·
May 14

Armata Q1 FY26 net loss widens to $115.35 million

Reuters
·
May 14

Armata Pharmaceuticals Inc - Q1 Net Loss $115.3 Mln or $3.16 Loss per Share VS $6.5 Mln or $0.18 Loss Year Ago

THOMSON REUTERS
·
May 14

Armata Pharmaceuticals Inc - Enters Secured Credit Agreement With Innoviva for $25 Mln Maturing in 2029

THOMSON REUTERS
·
May 14

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-Sa02

THOMSON REUTERS
·
May 07

Armata Pharmaceuticals Inc - to Initiate Phase 3 Study of AP-Sa02 in H2 2026

THOMSON REUTERS
·
May 07

Armata reports cryo-EM study maps structure of Pseudomonas phage P7-1

Reuters
·
May 04

Armata Pharma director Daniel Gilmer files initial beneficial ownership statement

Reuters
·
Apr 29

Armata Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 28

Armata Pharmaceuticals appoints Pfizer executive Daniel Gilmer to board

Reuters
·
Apr 27

Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.d. to Its Board of Directors

THOMSON REUTERS
·
Apr 27

Press Release: Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors

Dow Jones
·
Apr 27

Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch

TIPRANKS
·
Apr 08